my 5445 has been researched along with Leukemia, Megakaryocytic in 1 studies
MY 5445: potential platelet aggregation inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zurbonsen, K | 1 |
| Michel, A | 1 |
| Vittet, D | 1 |
| Bonnet, PA | 1 |
| Chevillard, C | 1 |
1 other study available for my 5445 and Leukemia, Megakaryocytic
| Article | Year |
|---|---|
Dissociation between phosphodiesterase inhibition and antiproliferative effects of phosphodiesterase inhibitors on the Dami cell line.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Alprostadil; Cell Division; Cyclic AMP; Humans; Isoe | 1997 |